Occult hepatitis B virus infection in patients with hepatitis C virus chronic hepatitis is not due to HBV genomic mutations and is related with severity of liver disease and lack of response to interferon therapy
Cacciola, I.; Pollicino, T.; Squadrito, G.; Cerenzia, G.; Longo, G.; Raimondo, G.
Hepatology 28(4 Part 2): 723A
1998
ISSN/ISBN: 0270-9139
Accession: 032611356
PDF emailed within 1 workday: $29.90
Related References
Berg, T.; Naumann, U.; Heuft, H.G.; Kuether, S.; Lobeck, H.; Schreier, E.; Hopf, U. 1996: Hepatitis G virus infection in patients with chronic hepatitis C Severity of liver disease and response to interferon-alpha Hepatology 24(4 Part 2): 226AFabris, P.; Brown, D.; Tositti, G.; Bozzola, L.; Giordani, M.T.; Bevilacqua, P.; de Lalla, F.; Webster, G.J.M.; Dusheiko, G. 2004: Occult hepatitis B virus infection does not affect liver histology or response to therapy with interferon alpha and ribavirin in intravenous drug users with chronic hepatitis C Journal of Clinical Virology: the Official Publication of the Pan American Society for Clinical Virology 29(3): 160-166
Martinot, M.; Marcellin, P.; Boyer, N.; Detmer, J.; Pouteau, M.; Castelnau, C.; Degott, C.; Aupérin, A.; Collins, M.; Kolberg, J.; Wilber, J.; Benhamou, J.P.; Erlinger, S. 1997: Influence of hepatitis G virus infection on the severity of liver disease and response to interferon-alpha in patients with chronic hepatitis C Annals of Internal Medicine 126(11): 874-881
Fujiwara, K.; Tanaka, Y.; Orito, E.; Ohno, T.; Kato, T.; Sugauchi, F.; Suzuki, S.; Hattori, Y.; Sakurai, M.; Hasegawa, I.; Ozasa, T.; Kanie, F.; Kano, H.; Ueda, R.; Mizokami, M. 2004: Lack of association between occult hepatitis B virus DNA viral load and aminotransferase levels in patients with hepatitis C virus-related chronic liver disease Journal of Gastroenterology and Hepatology 19(12): 1343-1347
Giannini, E.; Botta, F.; Fasoli, A.; Romagnoli, P.; Chiarbonello, B.; Malfatti, F.; Fumagalli, A.; Testa, E.; Polegato, S.; Ansaldi, F.; Durando, P.; Testa, R. 2001: Prevalence and clinical associations of previous and occult hepatitis B virus infection in hepatitis C virus positive and hepatitis B virus surface antigen negative patients with chronic liver disease Hepatology 34(4 Pt 2): 562A
López-Labrador, F.X.; Ampurdanès, S.; Giménez-Barcons, M.; Guilera, M.; Costa, J.; Jiménez de Anta, M.T.; Sánchez-Tapias, J.M.; Rodés, J.; Sáiz, J.C. 1999: Relationship of the genomic complexity of hepatitis C virus with liver disease severity and response to interferon in patients with chronic HCV genotype 1b infection [correction of interferon Hepatology 29(3): 897-903
Tanaka, K. 2008: Does occult hepatitis B virus infection cause hepatocellular carcinoma in patients with chronic liver disease related to hepatitis C virus? Hepatology Research: the Official Journal of the Japan Society of Hepatology 38(6): 543-545
Silva, C.d.; Gonçales, N.S.L.; Pereira, J.S.F.; Escanhoela, C.íl.A.él.F.; Pavan, M.H.P.; Gonçales, F.L. 2004: The influence of occult infection with hepatitis B virus on liver histology and response to interferon treatment in chronic hepatitis C patients Brazilian Journal of Infectious Diseases: An Official Publication of the Brazilian Society of Infectious Diseases 8(6): 431-439
Kumar, G.T.; Kazim, S.N.; Kumar, M.; Hissar, S.; Chauhan, R.; Basir, S.F.; Sarin, S.K. 2009: Hepatitis B virus genotypes and hepatitis B surface antigen mutations in family contacts of hepatitis B virus infected patients with occult hepatitis B virus infection Journal of Gastroenterology and Hepatology 24(4): 588-598
Pawlotsky, J.M.; Roudot-Thoraval, F.; Muerhoff, A.S.; Pellerin, M.; Germanidis, G.; Desai, S.M.; Bastie, A.; Darthuy, F.; Rémiré, J.; Zafrani, E.S.; Soussy, C.J.; Mushahwar, I.K.; Dhumeaux, D. 1998: GB virus C (GBV-C) infection in patients with chronic hepatitis C. Influence on liver disease and on hepatitis virus behaviour: Effect of interferon alfa therapy Journal of Medical Virology 54(1): 26-37
Fabris, P.; Brown, D.; Tositti, G.; Bozzola, L.; Giordani, M.T.; Bevilacqua, P.; De Lalla, F.; Dusheiko, G. 2003: Impact on liver histology and relationship with response to combination therapy of occult hepatitis B virus infection in patients with chronic hepatitis C Journal of Hepatology 38(Suppl 2): 139
Caruso, L.; Weber, J.N.; Forster, G.E.; Scully, L.; Harris, J.R.W.; Thomas, H.C. 1985: Effects of human t cell lymphotropic virus type iii virus infection on replication severity of liver disease and response to interferon in chronic hepatitis b virus carriers Journal of Hepatology (Suppl 2): S207
Bazinet, M.; Pântea, V.; Cebotarescu, V.; Cojuhari, L.; Jimbei, P.; Anderson, M.; Gersch, J.; Holzmayer, V.; Elsner, C.; Krawczyk, A.; Kuhns, M.C.; Cloherty, G.; Dittmer, U.; Vaillant, A. 2021: Persistent Control of Hepatitis B Virus and Hepatitis Delta Virus Infection Following REP 2139-Ca and Pegylated Interferon Therapy in Chronic Hepatitis B Virus/Hepatitis Delta Virus Coinfection Hepatology Communications 5(2): 189-202
Lopezlabrador, F.X.; Ampurdanes, S.; Gimenezbarcons, M.; Guilera, M.; Costa, J.; Jimenez de Anta, M.T.; Sancheztapias, J.M.; Rodes, J.; Saiz, J.C. 1999: Relationship of the genomic complexity of hepatitis C virus with liver disease severity and response to interferon in patients with chronic HCV genotype 1b interferon Hepatology (Baltimore, Md.) 29(3): 897-903
Myers, R.P.; Thibault, V.; Poynard, T. 2003: The impact of prior hepatitis B virus infection on liver histology and the response to interferon therapy in chronic hepatitis C Journal of Viral Hepatitis 10(2): 103-110
Branco, F.; Mattos, A.A.d.; Coral, G.P.; Vanderborght, B.; Santos, D.E.; França, P.; Alexandre, C.áu. 2007: Occult hepatitis B virus infection in patients with chronic liver disease due to hepatitis C virus and hepatocellular carcinoma in Brazil Arquivos de Gastroenterologia 44(1): 58-63
Rodríguez-Iñigo, E.; Mariscal, L.; Bartolomé, J.; Castillo, I.; Navacerrada, C.; Ortiz-Movilla, N.; Pardo, M.; Carreño, V. 2003: Distribution of hepatitis B virus in the liver of chronic hepatitis C patients with occult hepatitis B virus infection Journal of Medical Virology 70(4): 571-580
Hasegawa, I.; Orito, E.; Tanaka, Y.; Hirashima, N.; Sakakibara, K.; Sakurai, M.; Suzuki, S.; Sugauchi, F.; Ohno, T.; Ueda, R.; Mizokami, M. 2005: Impact of occult hepatitis B virus infection on efficacy and prognosis of interferon-alpha therapy for patients with chronic hepatitis C Liver International: Official Journal of the International Association for the Study of the Liver 25(2): 247-253
Hasegawa, I.; Orito, E.; Tanaka, Y.; Hirashima, N.; Sakakibara, K.; Ohno, T.; Sugauchi, F.; Suzuki, S.; Sakurai, M.; Fujiwara, K.; Ozasa, T.; Ueda, R.; Mizokami, M. 2002: Impact of occult hepatitis B virus infection on efficacy and prognosis of interferon-alpha therapy for patients with chronic hepatitis C Hepatology 36(4 Part 2): 369A
Makuza, J.D.; Jeong, D.; Binka, M.; Adu, P.A.; Cua, G.; Yu, A.; Velásquez García, H.éc.A.; Alvarez, M.; Wong, S.; Bartlett, S.; Karim, M.E.; Yoshida, E.M.; Ramji, A.; Krajden, M.; Janjua, N.Z. 2022: Impact of Hepatitis B Virus Infection, Non-alcoholic Fatty Liver Disease, and Hepatitis C Virus Co-infection on Liver-Related Death among people Tested for Hepatitis B Virus in British Columbia: Results from a Large Longitudinal Population-Based Cohort Study Viruses 14(11)